Inhibition of histone methyltransferase EZH2 for immune interception of colorectal cancer in Lynch syndrome.
Saved in:
| Title: | Inhibition of histone methyltransferase EZH2 for immune interception of colorectal cancer in Lynch syndrome. |
|---|---|
| Authors: | Bowen CM; Department of Clinical Cancer Prevention., Duzagac F; Department of Clinical Cancer Prevention., Martel-Martel A; Department of Clinical Cancer Prevention., Reyes-Uribe L; Department of Clinical Cancer Prevention., Zaheer M; Department of Clinical Cancer Prevention., Thompson J; Department of Clinical Cancer Prevention., Deng N; Department of Clinical Cancer Prevention., Sinha R; Department of Clinical Cancer Prevention., Mazumdar S; Department of Clinical Cancer Prevention., Taggart MW; Department of Pathology, and., Jain AK; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Tosti E; Department of Cell Biology, Albert Einstein College of Medicine, Bronx, New York, USA., Edelmann W; Department of Cell Biology, Albert Einstein College of Medicine, Bronx, New York, USA., Sinha KM; Department of Clinical Cancer Prevention., Vilar E; Department of Clinical Cancer Prevention. |
| Source: | JCI insight [JCI Insight] 2025 Feb 13; Vol. 10 (6). Date of Electronic Publication: 2025 Feb 13. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model: Electronic Cited Medium: Internet ISSN: 2379-3708 (Electronic) Linking ISSN: 23793708 NLM ISO Abbreviation: JCI Insight Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
